ProVent Study is a randomized Phase 3, Open-label Trial of Sipuleucel-T administered to patients on active surveillance for newly diagnosed prostate cancer. What is the ProVent Study? The ProVent study is a randomized, open-label study designed to look at whether sipuleucel-T can slow the progression of prostate cancer for subjects in active surveillance, following sipuleucel-T…
Read more
ProVent Study
